Strategic Focus Target oncology and expanding into neurology by highlighting the company’s core mission to develop and supply radiopharmaceuticals for PET imaging, presenting growth opportunities in adjacent disease areas and personalized nuclear medicine services.

European Partner Position as Europe’s preferred precision diagnostic partner for PET imaging to expand regional market share, emphasizing supply reliability, testing, and timely delivery of radiopharmaceutical products.

Technical Ecosystem Leverage existing tech stack relationships (SAP MDG, PTC Windchill, Cadence, Fortinet, Platform.sh) to offer integrated digital solutions for product lifecycle management, regulatory compliance, and security to potential customers and contract manufacturers.

Financial Footprint With mid-range revenue and significant funding, pursue strategic partnerships, co-development, and equipment or service deals that align with capacity to scale radiopharmacy manufacturing and clinical deployment.

Talent & Expansion Capitalize on recent hires and training partnerships to propose service agreements, field support, and maintenance contracts for imaging and PET radiopharmaceutical workflows across new and existing sites.